CK Life Sciences Intl Holdings Inc 2025 SR
The report outlines CK Life Sciences' sustainability performance and strategic initiatives for the fiscal year 2025. A major highlight is the acquisition of over 350,000 hectares of Australian agricultural land for a large-scale regenerative agriculture and carbon sequestration project. The company also developed a comprehensive low-carbon transition plan, disclosed its Scope 3 greenhouse gas emissions for the first time, and conducted quantitative climate scenario analysis. Additionally, the company maintained its record of zero work-related fatalities while continuing to advance its pharmaceutical and nutraceutical innovations.
Company: CK Life Sciences Intl Holdings Inc
Sector: Health Care
Country: Hong Kong
Year: 2025
Type: SR
Pages: 59
CK Life Sciences Intl Holdings Inc
Sustainability Report
The report outlines CK Life Sciences' sustainability performance and strategic initiatives for the fiscal year 2025. A major highlight is the acquisition of over 350,000 hectares of Australian agricultural land for a large-scale regenerative agriculture and carbon sequestration project. The company also developed a comprehensive low-carbon transition plan, disclosed its Scope 3 greenhouse gas emissions for the first time, and conducted quantitative climate scenario analysis. Additionally, the company maintained its record of zero work-related fatalities while continuing to advance its pharmaceutical and nutraceutical innovations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees